+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men



Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men



Metabolism, Clinical and Experimental 53(4): 423-429



We investigated the association among plasma levels of oxidatively modified low-density lipoprotein (Ox-LDL), high-density lipoprotein-cholesterol (HDL-C), and the prevalence of coronary artery disease (CAD) in a case-control study. Cases (n=183; male, M/female, F:138/45, age: 64.9+or-10.6 years) were defined as patients with angiographically proven coronary atherosclerosis (>=50% stenosis) and controls were subjects with normal coronary arteries (n=74, M/F:36/38, age: 57.6+or-14.4 years).

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 004316143

Download citation: RISBibTeXText

PMID: 15045686

DOI: 10.1016/j.metabol.2003.10.028


Related references

Influence of risk factors on peripheral and cerebrovascular disease in men with coronary artery disease, low high-density lipoprotein cholesterol levels, and desirable low-density lipoprotein cholesterol levels. HIT Investigators. Department of Veterans Affairs HDL Intervention Trial. American Heart Journal 136(4 Pt 1): 734-740, 1998

Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. Journal of the American College of Cardiology 55(1): 35-41, 2009

Cholesterol esterification rates in very low density lipoprotein- and low density lipoprotein-depleted plasma. Relation to high density lipoprotein subspecies, sex, hyperlipidemia, and coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology 11(1): 64-70, 1991

Cholesterol esterification rates in very low density lipoprotein and low density lipoprotein depleted plasma relation to high density lipoprotein subspecies sex hyperlipidemia and coronary artery disease. Arteriosclerosis & Thrombosis 11(1): 64-70, 1991

Modulation of lipoprotein(a) atherogenicity by high density lipoprotein cholesterol levels in middle-aged men with symptomatic coronary artery disease and normal to moderately elevated serum cholesterol. Journal of the American College of Cardiology 30(6): 1491-1499, 1997

Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial). American Journal of Cardiology 103(1): 41-45, 2009

Direct assessment of plasma low density lipoprotein and high density lipoprotein cholesterol levels and coronary heart disease: results from the Framingham Offspring Study. Atherosclerosis 213(1): 251-255, 2010

Differences in the metabolism of oxidatively modified low density lipoprotein and acetylated low density lipoprotein by human endothelial cells: inhibition of cholesterol esterification by oxidatively modified low density lipoprotein. Journal of Lipid Research 30(10): 1561-1568, 1989

Rationale and design of the Department of Veterans Affairs High-density lipoprotein cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol. American Journal of Cardiology 71(1): 45-52, 1993

Serum levels of remnant lipoprotein cholesterol and oxidized low-density lipoprotein in patients with coronary artery disease. Journal of Cardiology 53(1): 108-116, 2009

The association of coronary artery disease with levels of total and high-density lipoprotein cholesterol. FASEB Journal 7(3-4): A729, 1993

Serum Lipid, Lipoprotein and Oxidatively Modified Low Density Lipoprotein Levels in Active or Inactive Patients with Behçet's Disease. Indian Journal of Dermatology 57(2): 97, 2012

Effects of Low-density Lipoprotein Cholesterol on Coronary Artery Calcification Progression According to High-density Lipoprotein Cholesterol Levels. Archives of Medical Research 48(3): 284-291, 2017

Meta-analysis of the association between asthma and serum levels of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol. Annals of Allergy Asthma and Immunology 118(1): 61-65, 2017

The Veterans Affairs High-Density Lipoprotein Intervention Trial: baseline characteristics of normocholesterolemic men with coronary artery disease and low levels of high-density lipoprotein cholesterol. Veterans Affairs Cooperative Studies Program High-Density Lipoprotein Intervention Trial Study Group. American Journal of Cardiology 78(5): 572-575, 1996